As of Dec 15
| 0.00 / 0.00%|
The 6 analysts offering 12-month price forecasts for Ligand Pharmaceuticals Inc have a median target of 154.00, with a high estimate of 170.00 and a low estimate of 105.00. The median estimate represents a +13.34% increase from the last price of 135.87.
The current consensus among 6 polled investment analysts is to Buy stock in Ligand Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.